SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-009839
Filing Date
2021-03-01
Accepted
2021-03-01 16:04:59
Documents
14
Period of Report
2021-02-23
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K xene-8k_20210223.htm   iXBRL 8-K 39496
2 EX-99.1 xene-ex991_6.htm EX-99.1 177004
3 GRAPHIC g3sihi3hfm5f000001.jpg GRAPHIC 6853
  Complete submission text file 0001564590-21-009839.txt   371290

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA xene-20210223.xsd EX-101.SCH 5792
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE xene-20210223_lab.xml EX-101.LAB 19435
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xene-20210223_pre.xml EX-101.PRE 11629
7 EXTRACTED XBRL INSTANCE DOCUMENT xene-8k_20210223_htm.xml XML 3536
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Filer) CIK: 0001582313 (see all company filings)

IRS No.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36687 | Film No.: 21697673
SIC: 2834 Pharmaceutical Preparations